Timothy Rolph's Stock Transactions in Akero Therapeutics, Inc.

Timothy Rolph, Chief Scientific Officer of Akero Therapeutics, Inc., reported several stock transactions on August 5, 2025. These transactions included the exercise of stock options for 12,500 shares at a price of $21.09 per share, resulting in a total of 7,433 shares owned following the transaction. Additionally, Rolph sold 5,538 shares at a weighted-average price of $49.065 and 6,962 shares at a weighted-average price of $49.494. These sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024. Following these transactions, Rolph owns a total of 167,124 shares of common stock in Akero Therapeutics, Inc.